Teblik Drugs Private Limited

Teblik Drugs Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U24232MP1989PTC005061 Incorporated 02 February 1989 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2025
₹3.05 Cr
▲ 2% YoY
Net profit · FY 2025
₹1.8 Lakh
Net margin 0.6%
EBITDA · FY 2025
₹10.11 Lakh
EBITDA margin 3.3%
Authorised capital
₹35 Lakh
Registered with MCA
Paid-up capital
₹25.11 Lakh
Issued & subscribed
Open charges
₹75 Lakh
Satisfied ₹4.12 Cr
Company age
37 yrs
Est. 1989
Employees · EPFO
19
Provident fund records

About Teblik Drugs Private Limited

Data last updated:

Teblik Drugs Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 February 1989 and has been in existence for over 37 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP1989PTC005061. Its GSTIN is 23AABCT2489G1ZD (Madhya Pradesh).

The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹25.11 Lakh. It was formerly known as Teblik Drugs Limited. It is led by directors including Soham Prakash Sharma and Renu Sharma.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 17/1 North Rajmohalla, Indore, Madhya Pradesh, India – 452002.

As per the financials filed for FY 2025, the company reported a revenue of ₹3.05 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.8 Lakh (net margin 0.6%) and EBITDA of ₹10.11 Lakh (EBITDA margin 3.3%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 4% over five years.

The company has about 19 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹75 Lakh and satisfied charges of ₹4.12 Cr on record. Court records list 2 cases involving the company, including 2 filed against it.

Teblik Drugs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0021365). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website teblikdrugs.com.

Company details

CIN U24232MP1989PTC005061
Registration Number 005061
Incorporation Date 02 February 1989
ROC Gwalior
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MP-23-0021365

CIN history

Teblik Drugs has one previous CIN (Corporate Identification Number): U24232MP1989PLC005061. The current CIN is U24232MP1989PTC005061, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232MP1989PTC005061Current
U24232MP1989PLC005061Previous
Key People
Soham Prakash Sharma Director Renu Sharma Director Shobhit Sharma Director

Recognitions & Rankings of Teblik Drugs

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MP-23-0021365

Contact details

Teblik Drugs Private Limited's registered office is in Indore, Madhya Pradesh. Its website is teblikdrugs.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    teblikdrugs.com
  • Registered Address
    17/1 North Rajmohalla, Indore, Madhya Pradesh, India – 452002
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Teblik Drugs Private Limited, buy the company report.

Comprehensive company report
Teblik Drugs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Teblik Drugs is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Teblik Drugs Private Limited, buy the company report.

Financials of Teblik Drugs Private Limited

FY 2025 filings available

Teblik Drugs Private Limited reported revenue of ₹3.05 Cr (up 2% YoY) for FY 2025.

Revenue · FY 2025
₹3.05 Cr ▲ 2%
Net profit · FY 2025
₹1.8 Lakh margin 0.6%
EBITDA · FY 2025
₹10.11 Lakh margin 3.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 4%
5 years · compounded
▲ 4%
EBITDA CAGR growth
3 years · compounded
▼ 6%
5 years · compounded
▼ 6%

Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 2% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹10.11 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.8 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin3.3%
Net Profit Margin0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Teblik Drugs Private Limited, buy the company report.

Board of directors of Teblik Drugs Private Limited

Teblik Drugs has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Soham Prakash SharmaDirector02 Feb 198937 Years 9 MonthsCurrent
Renu SharmaDirector28 Mar 201412 Years 7 MonthsCurrent
Shobhit SharmaDirector28 Mar 201412 Years 7 MonthsCurrent
View all directors

Auditor

Teblik Drugs Private Limited is audited by M.K.SHAH & ASSOCIATES for the financial year 2017.

Auditor firmFinancial yearFirm registration number
M.K.SHAH & ASSOCIATESFY 2017071199

Shareholding

The shareholding of Teblik Drugs Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Teblik Drugs Private Limited, buy the company report.

Charges & borrowings

Open charges
₹75 Lakh
Satisfied charges
₹4.12 Cr
Breakdown by lending institutions
Others₹0.75 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
24 Oct 2025101181977Others₹75 LakhOpen
31 May 2022100579023Others₹50 LakhSatisfied
23 Jun 2016100042702Others₹36 LakhSatisfied
29 Jun 200910164524Small Industries Development Bank of India₹25 LakhSatisfied
13 Jun 200710060453Bank of Baroda₹2.01 CrSatisfied

To see the full charge records of Teblik Drugs Private Limited, buy the company report.

Total charge records: 11 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Teblik Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Teblik Drugs Private Limited has a workforce of 19 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
19
Active EPFO establishments
1

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2719
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Teblik Drugs Private Limited, buy the company report.

GST

Teblik Drugs has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
23AABCT2489G1ZDMadhya PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Teblik Drugs Private Limited, buy the company report.

Recent activity

Teblik Drugs Private Limited has 5 board changes on record since 1989: 3 appointments and 2 cessations. The latest: Satyanarayan Rathore ceased to be Director on 11 Nov 2017.

Charges
A charge registered on 31 May 2022 via Charge ID 100579023 with Others was fully satisfied on 10 Nov 2025.
Charges
A charge with Others amounted to Rs. 75.00 Lakh with Charge ID 101181977 was registered on 24 Oct 2025.
AGM
Teblik Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Teblik Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 100579023 was registered on 31 May 2022.
Charges
A charge registered on 23 Jun 2016 via Charge ID 100042702 with Others was fully satisfied on 18 May 2022.
Charges
A charge with Others of Rs. 36.00 Lakh registered on 23 Jun 2016 with Charge ID 100042702 was modified on 09 Feb 2022.
Ceased
Satyanarayan Rathore ceased to be Director.
Charges
A charge registered on 13 Jun 2007 via Charge ID 10060453 with Bank Of Baroda was fully satisfied on 12 Jul 2016.
Charges
A charge with Others amounted to Rs. 36.00 Lakh with Charge ID 100042702 was registered on 23 Jun 2016.
Ceased
Anil Bhatia ceased to be Director.
Appointed
Renu Sharma was appointed as Director.

24 earlier events are in the company report.

Frequently asked questions

Teblik Drugs is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 February 1989 (37+ years old) and is registered under CIN U24232MP1989PTC005061.

Teblik Drugs has 3 current directors:

The latest financial statements of Teblik Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Teblik Drugs is 23AABCT2489G1ZD, registered in Madhya Pradesh.

The CIN (Corporate Identification Number) of Teblik Drugs is U24232MP1989PTC005061. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Teblik Drugs has 2 court cases on record: 2 filed against it. Most are in the district courts.

Teblik Drugs was incorporated on 02 February 1989, making it 37+ years old. It is registered with the Registrar of Companies, Gwalior.

Satyanarayan Rathore ceased to be Director on 11 Nov 2017. Anil Bhatia ceased to be Director on 01 Apr 2014. Renu Sharma was appointed as Director on 28 Mar 2014. Teblik Drugs has 5 board changes on record in total.

Yes, Teblik Drugs is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0021365).

Teblik Drugs can be reached through the website teblikdrugs.com. Its registered office is in Indore, Madhya Pradesh, India.